Lung Cancer Clinical Trials in Columbia, SC

Lung Cancer Clinical Trials in Columbia, SC

View the best 10 lung cancer medical studies in Columbia, South Carolina. Access promising new therapies by applying to a Columbia-based Lung Cancer clinical trial.

Trials in Columbia, South Carolina

Here are the top 10 medical studies for lung cancer in Columbia, South Carolina

Image of Saint Francis Medical Center in Cape Girardeau, United States.

Stereotactic Radiosurgery +1 More

Radiation Therapy

Recruiting2 awardsPhase 3
This trial compares the effect of stereotactic radiosurgery to standard of care memantine and whole brain radiation therapy that avoids the hippocampus for the treatment of small cell lung cancer that has spread to the brain.
Image of Children's Hospital of Alabama in Birmingham, United States.

Cyclophosphamide +8 More

Alkylating agents

Recruiting2 awardsPhase 3
This trial is testing how well combination chemotherapy works with or without the drug ganitumab in treating patients with newly diagnosed Ewing sarcoma.
Image of Grady Health System in Atlanta, United States.

Durvalumab +2 More

PD-L1 Inhibitor

Recruiting1 awardPhase 1
This trial is testing two different radiation schedules with durvalumab to see which is better at treating NSCLC.
Image of OPN Healthcare, Inc. in Glendale, United States.

Zongertinib

Tyrosine Kinase Inhibitor

Recruiting2 awardsPhase 3
"This trial is looking for adults with advanced lung cancer who have not yet received chemotherapy. The study aims to see if a new medication called BI 1810631 (zongertinib) can
Image of Reading Hospital in West Reading, United States.

Durvalumab +6 More

Immunotherapy

Recruiting2 awardsPhase 3
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Image of Sutter Auburn Faith Hospital in Auburn, United States.

Pembrolizumab +2 More

Monoclonal Antibodies

Recruiting2 awardsPhase 3
This trial compares ramucirumab+pembrolizumab vs chemo for non-small cell lung cancer. Ramucirumab+pembrolizumab may stop tumors from growing and spreading, while chemo kills/stops cells from dividing/spreading. Results may help find out if this combo is more effective than chemo.
Image of Cancer Care of North Florida in Lake City, United States.

NovoTTF-200T

Device

Recruiting1 awardPhase 2
This trial is testing a device that sends electric fields to the chest to treat lung cancer along with the drug pembrolizumab. The aim is to see if the combination can help people with lung cancer who haven't been treated before.
Image of Alaska Clinical Research Center in Anchorage, United States.

Nivolumab +4 More

PD-1/PD-L1 Checkpoint Inhibitor

Recruiting1 awardPhase 2
This trial tests a combination of treatments that aim to boost the immune system in patients whose cancer has progressed after previous treatments. Some patients may receive an additional therapy if their disease continues to progress.
Image of TRIO - Translational Research in Oncology-US, Inc. in Los Angeles, United States.

Ramucirumab +3 More

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial is testing a new drug combination to treat patients with advanced lung cancer who have specific genetic changes. The treatment aims to stop cancer growth by cutting off its blood supply and blocking growth signals. One of the drugs being tested has shown significant survival benefits when combined with other treatments in advanced lung cancer.
Image of Highlands Oncology Group in Springdale, United States.

Atezolizumab

Checkpoint Inhibitor

Recruiting2 awardsPhase 3
This trial is testing a new cancer treatment against the current best treatment, to see if the new treatment is more effective in preventing the cancer from returning.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.